Intranasal flu vaccine under scrutiny

An influenza vaccine delivered intranasally should not be given in any setting during the 2016-17 flu season in the US, its manufacturer has said.AstraZeneca confirmed that the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention has provided its interim recommendation on the use of FluMist Quadrivalent Live Attenuated Influenza Vaccine